Physician profile
Edward Garza
NPI 1043322274
$25,110.43
in general payments reported to CMS, 2019-2025
17 companies · $703 in 2025
The $703 reported for 2025 was more than what 85% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $5,044 · 2021: $3,418 · 2022: $869 · 2023: $953 · 2024: $853 · 2025: $703.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,489 · Entertainment: $20.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,488.96 |
| Entertainment | $20.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $21,173.45 | 2019-2024 | Myday Contact Lens, Misight Contact Lens |
| Alcon Vision LLC | $1,987.56 | 2019-2025 | Total30, Precision 1, Precision7 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $321.37 | 2019-2020 | |
| Bausch & Lomb Americas INC. | $303.54 | 2024-2025 | Miebo, Xiidra, Infuse |
| Abb Con-Cise Optical Group LLC | $292.48 | 2019-2020 | |
| Glaukos Corporation | $194.97 | 2022-2023 | Kxl System (Not Refurbished), Istent Inject Trabecular Micro-Bypass System |
| Rxsight INC | $110.86 | 2024 | Light Adjustable Lens (Lal), Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
| Johnson & Johnson Surgical Vision, INC. | $110.60 | 2020 | |
| Johnson & Johnson Vision Care, INC. | $106.28 | 2023 | Acuvue |
| Myovant Sciences INC. | $101.37 | 2022 | |
| Biotissue Holdings INC. | $93.26 | 2022 | |
| Hologic Sales and Service, LLC | $90.39 | 2019 | |
| Abbvie INC. | $66.93 | 2022-2023 | |
| Optos, INC. | $57.90 | 2022-2024 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Lkc Technologies, INC. | $44.85 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $35.20 | 2020 | |
| Tarsus Pharmaceuticals, INC. | $19.42 | 2025 | Xdemvy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Garza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.